|
DNAJB11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72699999973136E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.963500E-04 |
| Normal-vs-Stage2 |
1.172990E-01 |
| Normal-vs-Stage3 |
5.203300E-03 |
| Normal-vs-Stage4 |
3.357000E-01 |
| Stage1-vs-Stage2 |
8.063200E-01 |
| Stage1-vs-Stage3 |
6.701900E-02 |
| Stage1-vs-Stage4 |
6.963800E-01 |
| Stage2-vs-Stage3 |
2.068600E-01 |
| Stage2-vs-Stage4 |
6.855400E-01 |
| Stage3-vs-Stage4 |
8.826100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79820000001385E-06 |
| Normal-vs-AfricanAmerican |
4.446300E-04 |
| Normal-vs-Asian |
2.408800E-01 |
| Caucasian-vs-AfricanAmerican |
9.198600E-01 |
| Caucasian-vs-Asian |
4.619000E-01 |
| AfricanAmerican-vs-Asian |
4.559200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.65820000000272E-05 |
| Normal-vs-Female |
1.18469999998982E-06 |
| Male-vs-Female |
9.042500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.676100E-03 |
| Normal-vs-Extreme_Weight |
1.642300E-04 |
| Normal-vs-Obese |
8.008500E-04 |
| Normal-vs-Extreme_Obese |
2.613000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.195800E-01 |
| Normal_Weight-vs-Obese |
6.445400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.547600E-01 |
| Extreme_Weight-vs-Obese |
8.695400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.135200E-01 |
| Obese-vs-Extreme_Obese |
5.950600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.179800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.68009999995866E-06 |
| Normal-vs-Age(61-80Yrs) |
5.63000000000091E-05 |
| Normal-vs-Age(81-100Yrs) |
1.908200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.241600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.387800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.055980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.803400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.299800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.556200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.16109999995329E-06 |
| Normal-VS-Type2 PRCC |
4.719800E-03 |
| Normal-VS-KIRP CIMP |
3.120100E-02 |
| Normal-VS-Unclassified PRCC |
7.217600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.784400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.600400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.074800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.425400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.937400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.864400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.424700E-03 |
| Normal-vs-N1 |
8.418900E-03 |
| Normal-vs-N2 |
4.073200E-01 |
| N0-vs-N1 |
8.012400E-02 |
| N0-vs-N2 |
6.420800E-01 |
| N1-vs-N2 |
7.849200E-01 |
|
|
